BIMI International Medical (NASDAQ:BIMI – Get Rating) and Cardinal Health (NYSE:CAH – Get Rating) are both medical companies, but which is the best investment? We’ll compare the two companies based on earnings strength, profitability, dividends, analyst recommendations, valuation, risk, and institutional ownership.
Institutional and insider ownership
20.3% of BIMI International Medical shares are held by institutional investors. By comparison, 84.3% of Cardinal Health shares are held by institutional investors. 9.8% of the shares of BIMI International Medical are held by insiders of the company. By comparison, 0.4% of Cardinal Health shares are held by insiders of the company. Strong institutional ownership indicates that endowments, hedge funds, and large fund managers believe a stock will outperform the market over the long term.
Risk and Volatility
BIMI International Medical has a beta of 0.19, suggesting its stock price is 81% less volatile than the S&P 500. In comparison, Cardinal Health has a beta of 0.82, suggesting its stock price is 18% less volatile than the S&P 500.
This table compares the net margins, return on equity and return on assets of BIMI International Medical and Cardinal Health.
|Net margins||Return on equity||return on assets|
|BIMI Medical International||-129.19%||-138.12%||-65.47%|
Benefits and evaluation
This table compares the revenue, earnings per share and valuation of BIMI International Medical and Cardinal Health.
|Gross revenue||Price/sales ratio||Net revenue||Earnings per share||Price/earnings ratio|
|BIMI Medical International||$27.08 million||0.38||-$34.99 million||N / A||N / A|
|Cardinal Health||$162.47 billion||0.10||$611.00 million||$1.91||31.67|
Cardinal Health has higher revenues and profits than BIMI International Medical.
This is a breakdown of current recommendations and price targets for BIMI International Medical and Cardinal Health, as reported by MarketBeat.
|Sales Ratings||Hold odds||Buy reviews||Strong buy odds||Rating|
|BIMI Medical International||0||0||0||0||N / A|
Cardinal Health has a consensus target price of $58.44, indicating a potential downside of 3.38%. Given Cardinal Health’s possible higher upside, analysts clearly believe that Cardinal Health is more favorable than BIMI International Medical.
Cardinal Health beats BIMI International Medical on 9 out of 11 factors compared between the two stocks.
About BIMI International Medical (Get a rating)
BIMI International Medical Inc., together with its subsidiaries, is engaged in the retail and wholesale distribution of medical devices, pharmaceuticals and other healthcare products in the People’s Republic of China. It offers prescription and over-the-counter medicines, nutritional supplements, health foods and miscellaneous products, as well as traditional Chinese medicines, personal and family care products and miscellaneous items under the Lijiantang Pharmacy brand. The company also provides IT research and development services. It sells its medicines and other health products to its customers through its directly owned stores. The company was previously known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Dalian, People’s Republic of China .
About Cardinal Health (Get a rating)
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia and internationally. It provides customized solutions for hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories, medical offices and home patients. The Company operates in two segments, pharmaceutical and medical. The Pharmaceuticals segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter health and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceuticals; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter health products; and provides medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and pharmacy management services to hospitals. The Medical segment manufactures, procures and distributes Cardinal Health branded medical, surgical and laboratory products and devices, including examination and surgical gloves; needles, syringes and sharp objects; cuts; incontinence; nutritional delivery products; wound care preparations; single-use surgical drapes, gowns and clothing; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers; and assembles and sells sterile and non-sterile procedural kits. It has a collaboration agreement with Journey Biosciences, Inc. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Get news and reviews for BIMI International Medical Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for BIMI International Medical and related companies with MarketBeat.com’s free daily email newsletter.